| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.006 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.006 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.007 |
| mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
| mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.008 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
| mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.01 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
| mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.01 |